Actively Recruiting
To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers
Led by JW Pharmaceutical · Updated on 2025-01-13
72
Participants Needed
1
Research Sites
51 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial is a randomized, double-blind, placebo-controlled, single ascending dose, phase 1 clinical trial to evaluate the safety/tolerability and pharmacokinetic characteristics, and to explore food effect and ethnic difference of JW2286 after oral administration in healthy adults.
CONDITIONS
Official Title
To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy Korean or Caucasian volunteers
You will not qualify if you...
- Individuals with a clinically significant disease or history
- Individuals with a history of a gastrointestinal disorder or surgery
- Female individuals with childbearing potential, except those who are surgically sterile
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital Clinical Trial Center
Seoul, South Korea
Actively Recruiting
Research Team
H
Hyeona Kim
CONTACT
S
Soojin Park
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here